MedTrace Logo

Trauma Equivalency Study of the CORA® and TEG® 5000 Systems

NCT02408029 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 325

Last updated 2016-01-27

No results posted yet for this study

Summary

This study is being performed to obtain data about the CORA System when used in a trauma clinical setting. The CORA analyzer is a new device that is currently being tested in trauma clinical applications and is not yet cleared for this purpose by the Food and Drug Administration (FDA) for sale in the United States.

Conditions

Interventions

OTHER

Observational study - no intervention

Sponsors & Collaborators

  • Coramed Technologies LLC

    lead INDUSTRY

Principal Investigators

  • Charles E Wade, Ph.D. · The University of Texas Health Science Center, Houston

  • Martin A Schreiber, M.D. · Oregon Health and Science University

  • Mark Walsh, M.D. · Indiana School of Medicine, South Bend Notre Dame Campus

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2015-10-31
Completion
2015-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02408029 on ClinicalTrials.gov